Dmitry Balyasny’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,518,170
| Closed | -$13.8M | – | 3405 |
|
|
2025
Q2 | $13.8M | Buy |
1,518,170
+1,404,441
| +1,235% | +$10.3M | 0.02% | 815 |
|
|
2025
Q1 | $904K | Buy |
+113,729
| New | +$833K | ﹤0.01% | 2037 |
|
|
2022
Q4 | – | Sell |
-33,794
| Closed | -$1.32M | – | 3179 |
|
|
2022
Q3 | $1.32M | Sell |
33,794
-301,872
| -90% | -$11.7M | ﹤0.01% | 1688 |
|
|
2022
Q2 | $10.8M | Buy |
335,666
+316,390
| +1,641% | +$10.6M | 0.04% | 625 |
|
|
2022
Q1 | $638K | Buy |
+19,276
| New | +$725K | ﹤0.01% | 1751 |
|
|
2020
Q4 | – | Sell |
-142,289
| Closed | -$8.7M | – | 1650 |
|
|
2020
Q3 | $8.7M | Buy |
+142,289
| New | +$7.21M | 0.06% | 429 |
|
|
2020
Q2 | – | Sell |
-19,038
| Closed | -$547K | – | 1445 |
|
|
2020
Q1 | $547K | Sell |
19,038
-133,467
| -88% | -$7.73M | 0.01% | 886 |
|
|
2019
Q4 | $11M | Buy |
+152,505
| New | +$18.8M | 0.07% | 399 |
|
|
2018
Q4 | – | Sell |
-75,593
| Closed | -$8.65M | – | 1707 |
|
|
2018
Q3 | $10.7M | Buy |
75,593
+61,362
| +431% | +$9.47M | 0.05% | 471 |
|
|
2018
Q2 | $2.23M | Sell |
14,231
-223,900
| -94% | -$35.2M | 0.01% | 895 |
|
|
2018
Q1 | $38.4M | Sell |
238,131
-23,069
| -9% | -$3.92M | 0.16% | 178 |
|
|
2017
Q4 | $43M | Sell |
261,200
-98,602
| -27% | -$9.56M | 0.13% | 186 |
|
|
2017
Q3 | $22.4M | Buy |
359,802
+169,302
| +89% | +$13.3M | 0.09% | 298 |
|
|
2017
Q2 | $15.2M | Sell |
190,500
-65,443
| -26% | -$4.73M | 0.06% | 402 |
|
|
2017
Q1 | $18.2M | Sell |
255,943
-121,417
| -32% | -$7.11M | 0.08% | 305 |
|
|
2016
Q4 | $19.3M | Buy |
377,360
+147,354
| +64% | +$6.95M | 0.1% | 282 |
|
|
2016
Q3 | $10.6M | Buy |
230,006
+118,097
| +106% | +$4.81M | 0.06% | 376 |
|
|
2016
Q2 | $3.37M | Buy |
+111,909
| New | +$3.73M | 0.02% | 594 |
|
|
2016
Q1 | – | Sell |
-26,250
| Closed | -$1.53M | – | 1494 |
|
|
2015
Q4 | $1.53M | Buy |
+26,250
| New | +$1.3M | 0.01% | 675 |
|
Other funds holding SAGE
IA
HNB
Dmitry Balyasny's SAGE Position: Q3 2025 in Review
Dmitry Balyasny sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 1,518,170 shares — an estimated $13.8M sold.
Dmitry Balyasny first reported a position in SAGE in Q4 2015 and held it in 19 quarters. The position peaked at $43M in Q4 2017. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Dmitry Balyasny reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Dmitry Balyasny sold 1,518,170 Sage Therapeutics shares in Q3 2025, an estimated $13.8M.
- Dmitry Balyasny first reported a position in Sage Therapeutics in Q4 2015 and held it in 19 quarters.
- Dmitry Balyasny's Sage Therapeutics position peaked at $43M in Q4 2017.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.